Campos, António http://orcid.org/0000-0003-0490-5889
Campos, Elisa J.
do Carmo, Anália
Patrício, Miguel
Castro de Sousa, João P.
Ambrósio, António Francisco
Silva, Rufino
Funding for this research was provided by:
Fundação para a Ciência e a Tecnologia (Strategic Project (UID/NEU/04539/2013), and COMPETE-FEDER (POCI-01-0145-FEDER-007440, Postdoctoral Fellowship SFRH/BPD/93672/2013, through European Union and National funds and co-funded by Human Capital Operating Programme (Programa Operacional do Capital Humano, POCH)
Article History
Received: 9 May 2018
Revised: 7 July 2018
Accepted: 12 July 2018
First Online: 23 July 2018
Compliance with ethical standards
:
: Rufino Silva is a member of the Advisory Boards for Bayer, Alcon, Alimera, Allergan, Novartis, and Thea. All other authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.